State of Wisconsin Investment Board’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,304
Closed -$81.5K 2545
2025
Q4
$81.5K Buy
+26,304
New +$75.1K ﹤0.01% 2332
2022
Q4
Sell
-50,825
Closed -$609K 2565
2022
Q3
$609K Sell
50,825
-1,441
-3% -$17.9K ﹤0.01% 1861
2022
Q2
$437K Sell
52,266
-24,034
-31% -$186K ﹤0.01% 2135
2022
Q1
$662K Hold
76,300
﹤0.01% 1733
2021
Q4
$863K Hold
76,300
﹤0.01% 1502
2021
Q3
$959K Hold
76,300
﹤0.01% 1459
2021
Q2
$620K Hold
76,300
﹤0.01% 1620
2021
Q1
$706K Sell
76,300
-3,200
-4% -$32.3K ﹤0.01% 1468
2020
Q4
$769K Hold
79,500
﹤0.01% 1404
2020
Q3
$987K Buy
79,500
+11,000
+16% +$146K ﹤0.01% 1297
2020
Q2
$890K Buy
68,500
+2,300
+3% +$28.9K ﹤0.01% 1263
2020
Q1
$672K Buy
66,200
+36,200
+121% +$473K ﹤0.01% 1274
2019
Q4
$469K Hold
30,000
﹤0.01% 1467
2019
Q3
$504K Buy
30,000
+13,900
+86% +$276K ﹤0.01% 1323
2019
Q2
$357K Buy
+16,100
New +$308K ﹤0.01% 1404

Other funds holding GOSS

State of Wisconsin Investment Board's GOSS Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 26,304 shares — an estimated $81.5K sold.

State of Wisconsin Investment Board first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $987K in Q3 2020. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • State of Wisconsin Investment Board reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 26,304 Gossamer Bio shares in Q1 2026, an estimated $81.5K.
  • State of Wisconsin Investment Board first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
  • State of Wisconsin Investment Board's Gossamer Bio position peaked at $987K in Q3 2020.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.